aod9604 banned AOD 9604: Peptide Claims vs Clinical Reality, AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH’s side effects. The The Peptide Craze - Ground

Common side effects include: Injection site reactions pain, redness, or swelling at the injection site Mild diarrhoea or gastrointestinal upset usually transient Skin reactions itching or rash (uncommon) Hypokalaemia rare, occurring when severe megaloblastic anaemia is corrected rapidly Serious adverse effects are extremely rare but may include anaphylaxis in hypersensitive individuals

In preclinical studies this reduced fat-cell size without changes to diet

Lipotropic combinations are unlicensed in the UK and must be supplied as MHRA-regulated 'specials' on prescription

This dose was chosen based on a previous dose-escalation study and subsequent work demonstrating its efficacy to drive weight loss in a short period of time 8